Drawing for X XSOLIS

USPTO serial 98037799

X XSOLIS

Reviewed by CopyMark Law Group

Reg. 7525121Status 700Registered
Filing date
Status date
Registration date
Oct 1, 2024
Examiner
TOOLEY, DAVID E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with X XSOLIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Perry Gattegno

Perry Gattegno LITWIN KACH LLP200 N LASALLE, SUITE 1550CHICAGO, IL 60606United States

Goods and services

ClassDescriptionStatusFirst use
035Business data analysis services in the field of healthcare; Business management consulting services in the field of data and workflow of clinical documentation improvement programs; Business management consulting services in the field of data analytics and business data management services that utilize cognitive computing to support operational and financial workflows for healthcare organizations and payers; Business management consulting services in the field of physician advisor services; Health care utilization and review services; Information and data compiling and analyzing relating to business management; Managed care services, namely, utilization review and pre-certification services; Pharmaceutical cost management services and drug utilization review services; Tracking and monitoring claims for payment by hospitals, review and analysis of such claims, as well as the preparation, organization and presentation of the documents and data pertaining to such claims for others for account auditing purposesACTIVEDec 18, 2023
036Financial management in the field of revenue cycle management and health insurance claims denial management for healthcare organizations and payers; Medical insurance case and utilization review and insurance claims adjustment services for healthcare purchasers and payors and providers and Medicare beneficiariesACTIVEDec 18, 2023
042Platform as a service (PAAS) featuring computer software platforms for provision of predictive analytics and artificial intelligence to collect, sort and filter patient data for the purpose of providing optimal healthcare; Platform as a service (PAAS) featuring computer software platforms for physician advisor utilization review, namely, assisting physician advisors with review of clinical and insurance information of patients and determination of patient eligibility for and the medical necessity of treatment; Platform as a service (PAAS) featuring computer software platforms for healthcare payers, namely, providing payers access to patient information, medical cases, and payment authorization; Platform as a service (PAAS) featuring computer software platforms for healthcare providers to identify, organize, and obtain certification for in-home healthcare and treatment of qualifying patients; Platform as a service (PAAS) featuring computer software platforms for healthcare case management, namely, discharge planning, analysis of length-of-stay data, value-based care, and interoperability of healthcare; Platform as a service (PAAS) featuring computer software platforms for revenue cycle management and health insurance claims denial management for healthcare organizations and payers; Platform as a service (PAAS) featuring computer software platforms for healthcare utilization review and fostering of communication and collaboration between healthcare providers and payers; Software as a service (SAAS) services featuring software for provision of predictive analytics and artificial intelligence to collect, sort and filter patient data for the purpose of providing optimal healthcare; Software as a service (SAAS) services featuring software for hysician advisor utilization review, namely, assisting physician advisors with review of clinical and insurance information of patients and determination of patient eligibility for and the medical necessity of treatment; Software as a service (SAAS) services featuring software for healthcare payers, namely, providing payers access to patient information, medical cases, and payment authorization; Software as a service (SAAS) services featuring software for healthcare providers to identify, organize, and obtain certification for in-home healthcare and treatment of qualifying patients; Software as a service (SAAS) services featuring software for healthcare case management, namely, discharge planning, analysis of length-of-stay data, value-based care, and interoperability of healthcare; Software as a service (SAAS) services featuring software for revenue cycle management and health insurance claims denial management for healthcare organizations and payers; Software as a service (SAAS) services featuring software for healthcare utilization review and fostering of communication and collaboration between healthcare providers and payers; Software as a service (SAAS) services featuring software using artificial intelligence for evaluating, prioritizing, and indicating in real-time a graduated score to determine medical necessity utilization review decisions for patients that is used by healthcare providers, institutions, health plans, and payersACTIVEDec 18, 2023
044Health care services, namely, providing a database in the field of evaluating, rating, and indicating patient information and featuring inputting and collection of data and information all for treatment and diagnostic purposesACTIVEDec 18, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 1, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 29, 2024SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 29, 2024CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 9, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 8, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 20, 2024IUAFUSE AMENDMENT FILED—
Jun 20, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 14, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 14, 2024EX1GSOU EXTENSION 1 GRANTED—
Jun 14, 2024EXT1SOU EXTENSION 1 FILED—
Jun 14, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 19, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 24, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 24, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 4, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 18, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 18, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Sep 18, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 18, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 18, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 15, 2023DOCKASSIGNED TO EXAMINER—
Jul 18, 2023MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 16, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 15, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance